Green Synthesis of Genistein-Fortified Zinc Ferrite Nanoparticles as a Potent Hepatic Cancer Inhibitor: Validation through Experimental and Computational Studies

Chiagoziem A. Otuechere; Netra P. Neupane; Adewale Adewuyi; Prateek Pathak; Jurica Novak; Maria Grishina; Habibullah Khalilullah; Mariusz Jaremko; Amita Verma

doi:10.1002/cbdv.202300719

Green Synthesis of Genistein-Fortified Zinc Ferrite Nanoparticles as a Potent Hepatic Cancer Inhibitor: Validation through Experimental and Computational Studies

Chiagoziem A. Otuechere, Netra P. Neupane, Adewale Adewuyi, Prateek Pathak, Jurica Novak, Maria Grishina, Habibullah Khalilullah, Mariusz Jaremko, Amita Verma

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

In hepatic cancer, precancerous nodules account for damage and inflammation in liver cells. Studies have proved that phyto-compounds based on biosynthetic metallic nanoparticles display superior action against hepatic tumors. This study targeted the synthesis of genistein-fortified zinc ferrite nanoparticles (GENP) trailed by anticancer activity assessment against diethylnitrosamine and N-acetyl-2-aminofluorene induced hepatic cancer. The process of nucleation was confirmed by UV-Vis spectrophotometry, X-ray beam diffraction, field-emission scanning electron microscopy, and FTIR. An in vitro antioxidant assay illustrated that the leaves of Pterocarpus mildbraedii have strong tendency as a reducetant and, in the nanoformulation synthesis, as a natural capping agent. A MTT assay confirmed that GENP have a strong selective cytotoxic potential against HepG2 cancer cells. In silico studies of genistein exemplified the binding tendency towards human matrix metalloproteinase comparative to the standard drug marimastat. An in vivo anticancer evaluation showed that GENP effectively inhibit the growth of hepatic cancer by interfering with hepatic and non-hepatic biochemical markers.

Original language	English (US)
Journal	Chemistry & Biodiversity
DOIs	https://doi.org/10.1002/cbdv.202300719
State	Published - Jun 13 2023

Bibliographical note

KAUST Repository Item: Exported on 2023-06-19
Acknowledgements: The authors acknowledge the Alliance for Accelerating Excellence in Science in Africa (AESA) and partners, the Welcome Trust/DBT India Alliance, and the African Academy of Sciences (AAS), for Grant AIMF-20-002 to conduct this study. CAO acknowledges the Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj for technical and administrative support in the course of this study. JN thanks the Univer-sity of Zagreb, University Computing Centre — SRCE, for granting access to the Isabella computer cluster, and the University of Rijeka for support through the Uniri-mladi-prirod-22-8 grant. PP and MG acknowledged South Ural State University, Chelyabinsk, Russia under Priority 2030 program.

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/cbdv.202300719

https://repository.kaust.edu.sa/bitstream/10754/692664/1/Chemistry%20%20%20Biodiversity%20-%202023%20-%20Otuechere%20-%20Green%20Synthesis%20of%20Genistein%e2%80%90Fortified%20Zinc%20Ferrite%20Nanoparticles%20as%20a%20Potent_removed%20%281%29.pdf

Cite this

@article{b022e13ddfb74965bce3e8664be79bd6,

title = "Green Synthesis of Genistein-Fortified Zinc Ferrite Nanoparticles as a Potent Hepatic Cancer Inhibitor: Validation through Experimental and Computational Studies",

abstract = "In hepatic cancer, precancerous nodules account for damage and inflammation in liver cells. Studies have proved that phyto-compounds based on biosynthetic metallic nanoparticles display superior action against hepatic tumors. This study targeted the synthesis of genistein-fortified zinc ferrite nanoparticles (GENP) trailed by anticancer activity assessment against diethylnitrosamine and N-acetyl-2-aminofluorene induced hepatic cancer. The process of nucleation was confirmed by UV-Vis spectrophotometry, X-ray beam diffraction, field-emission scanning electron microscopy, and FTIR. An in vitro antioxidant assay illustrated that the leaves of Pterocarpus mildbraedii have strong tendency as a reducetant and, in the nanoformulation synthesis, as a natural capping agent. A MTT assay confirmed that GENP have a strong selective cytotoxic potential against HepG2 cancer cells. In silico studies of genistein exemplified the binding tendency towards human matrix metalloproteinase comparative to the standard drug marimastat. An in vivo anticancer evaluation showed that GENP effectively inhibit the growth of hepatic cancer by interfering with hepatic and non-hepatic biochemical markers.",

author = "Otuechere, {Chiagoziem A.} and Neupane, {Netra P.} and Adewale Adewuyi and Prateek Pathak and Jurica Novak and Maria Grishina and Habibullah Khalilullah and Mariusz Jaremko and Amita Verma",

note = "KAUST Repository Item: Exported on 2023-06-19 Acknowledgements: The authors acknowledge the Alliance for Accelerating Excellence in Science in Africa (AESA) and partners, the Welcome Trust/DBT India Alliance, and the African Academy of Sciences (AAS), for Grant AIMF-20-002 to conduct this study. CAO acknowledges the Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj for technical and administrative support in the course of this study. JN thanks the Univer-sity of Zagreb, University Computing Centre — SRCE, for granting access to the Isabella computer cluster, and the University of Rijeka for support through the Uniri-mladi-prirod-22-8 grant. PP and MG acknowledged South Ural State University, Chelyabinsk, Russia under Priority 2030 program.",

year = "2023",

month = jun,

day = "13",

doi = "10.1002/cbdv.202300719",

language = "English (US)",

journal = "Chemistry & Biodiversity",

issn = "1612-1872",

publisher = "Wiley",

}

TY - JOUR

T1 - Green Synthesis of Genistein-Fortified Zinc Ferrite Nanoparticles as a Potent Hepatic Cancer Inhibitor: Validation through Experimental and Computational Studies

AU - Otuechere, Chiagoziem A.

AU - Neupane, Netra P.

AU - Adewuyi, Adewale

AU - Pathak, Prateek

AU - Novak, Jurica

AU - Grishina, Maria

AU - Khalilullah, Habibullah

AU - Jaremko, Mariusz

AU - Verma, Amita

N1 - KAUST Repository Item: Exported on 2023-06-19 Acknowledgements: The authors acknowledge the Alliance for Accelerating Excellence in Science in Africa (AESA) and partners, the Welcome Trust/DBT India Alliance, and the African Academy of Sciences (AAS), for Grant AIMF-20-002 to conduct this study. CAO acknowledges the Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj for technical and administrative support in the course of this study. JN thanks the Univer-sity of Zagreb, University Computing Centre — SRCE, for granting access to the Isabella computer cluster, and the University of Rijeka for support through the Uniri-mladi-prirod-22-8 grant. PP and MG acknowledged South Ural State University, Chelyabinsk, Russia under Priority 2030 program.

PY - 2023/6/13

Y1 - 2023/6/13

N2 - In hepatic cancer, precancerous nodules account for damage and inflammation in liver cells. Studies have proved that phyto-compounds based on biosynthetic metallic nanoparticles display superior action against hepatic tumors. This study targeted the synthesis of genistein-fortified zinc ferrite nanoparticles (GENP) trailed by anticancer activity assessment against diethylnitrosamine and N-acetyl-2-aminofluorene induced hepatic cancer. The process of nucleation was confirmed by UV-Vis spectrophotometry, X-ray beam diffraction, field-emission scanning electron microscopy, and FTIR. An in vitro antioxidant assay illustrated that the leaves of Pterocarpus mildbraedii have strong tendency as a reducetant and, in the nanoformulation synthesis, as a natural capping agent. A MTT assay confirmed that GENP have a strong selective cytotoxic potential against HepG2 cancer cells. In silico studies of genistein exemplified the binding tendency towards human matrix metalloproteinase comparative to the standard drug marimastat. An in vivo anticancer evaluation showed that GENP effectively inhibit the growth of hepatic cancer by interfering with hepatic and non-hepatic biochemical markers.

AB - In hepatic cancer, precancerous nodules account for damage and inflammation in liver cells. Studies have proved that phyto-compounds based on biosynthetic metallic nanoparticles display superior action against hepatic tumors. This study targeted the synthesis of genistein-fortified zinc ferrite nanoparticles (GENP) trailed by anticancer activity assessment against diethylnitrosamine and N-acetyl-2-aminofluorene induced hepatic cancer. The process of nucleation was confirmed by UV-Vis spectrophotometry, X-ray beam diffraction, field-emission scanning electron microscopy, and FTIR. An in vitro antioxidant assay illustrated that the leaves of Pterocarpus mildbraedii have strong tendency as a reducetant and, in the nanoformulation synthesis, as a natural capping agent. A MTT assay confirmed that GENP have a strong selective cytotoxic potential against HepG2 cancer cells. In silico studies of genistein exemplified the binding tendency towards human matrix metalloproteinase comparative to the standard drug marimastat. An in vivo anticancer evaluation showed that GENP effectively inhibit the growth of hepatic cancer by interfering with hepatic and non-hepatic biochemical markers.

UR - http://hdl.handle.net/10754/692664

UR - https://onlinelibrary.wiley.com/doi/10.1002/cbdv.202300719

U2 - 10.1002/cbdv.202300719

DO - 10.1002/cbdv.202300719

M3 - Article

C2 - 37312449

SN - 1612-1872

JO - Chemistry & Biodiversity

JF - Chemistry & Biodiversity

ER -

Green Synthesis of Genistein-Fortified Zinc Ferrite Nanoparticles as a Potent Hepatic Cancer Inhibitor: Validation through Experimental and Computational Studies

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this